project id: TCGA-LIHC; case submitter id: TCGA-DD-A73A; source center: 23; state: released; a260 a280 ratio: 1.85; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.08; rna integrity number: 7.5; age at index: 71; days to birth: -26136; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1941; age at diagnosis: 26136; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage I; ajcc pathologic t: T1; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 728.0; icd 10 code: C22.0; last known disease status: not reported; morphology: 8170/3; primary diagnosis: Hepatocellular carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Liver; synchronous malignancy: No; tissue or organ of origin: Liver; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 20.0; composition: Not Reported; days to collection: 287; days to sample procurement: 0; initial weight: 60.0; portion submitter id: TCGA-DD-A73A-01A-12; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 1.0; percent necrosis: 2.0; percent neutrophil infiltration: 1.0; percent normal cells: 0.0; percent stromal cells: 8.0; percent tumor cells: 90.0; percent tumor nuclei: 90.0;